Shares of gene sequencing company Complete Genomics, Inc. (NASDAQ:GNOM) gapped open higher Thursday after a 44 percent gain Wednesday following its announcement of its new Long Fragment Read technology that results in a 10-fold increase in accuracy and reduces the amount of DNA required for testing.
Don’t Miss: WOW! Google is Still Growing!
ImmunoGen (NASDAQ:IMGN) prices its secondary public offering of 6.25 million shares of common stock at $16 per share and expects to raise about $100 million less issue expenses. In a another development the company announced yesterday that it had initiated Phase I trials of its drug IMGN853 for ovarian cancer and other solid tumors over-expressing its folate receptor target.
The vagaries of the foreign currency market have adversely affected the financial results of both Procter & Gamble Co. (NYSE:PG) and Philip Morris International Inc. (NYSE:PM) – volatile currency values have become severe “headwinds” that have cut both revenues and profit.
According to the The Ars Technica technology news website, an unknown hacker group calling itself the D33DS Company managed to hack an unidentified sub-domain of Yahoo (NASDAQ:YHOO) servers, extracted details of 450,000 user accounts and passwords, and posted them online.